1. Home
  2. CALC vs SNES Comparison

CALC vs SNES Comparison

Compare CALC & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.97

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Logo SenesTech Inc.

SNES

SenesTech Inc.

HOLD

Current Price

$1.41

Market Cap

8.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALC
SNES
Founded
2011
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.7M
8.1M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
CALC
SNES
Price
$0.97
$1.41
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
969.0K
28.7K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.99
EPS
0.30
N/A
Revenue
N/A
$600,000.00
Revenue This Year
N/A
$29.00
Revenue Next Year
N/A
$95.04
P/E Ratio
$3.29
N/A
Revenue Growth
N/A
132.56
52 Week Low
$0.46
$1.41
52 Week High
$7.20
$5.99

Technical Indicators

Market Signals
Indicator
CALC
SNES
Relative Strength Index (RSI) 56.40 38.37
Support Level $0.52 N/A
Resistance Level $1.14 $1.76
Average True Range (ATR) 0.14 0.12
MACD 0.01 -0.02
Stochastic Oscillator 67.77 7.76

Price Performance

Historical Comparison
CALC
SNES

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.

Share on Social Networks: